Josef Parvizi
Fortuna: 48 M $ al 31/08/2026
Fortuna: 48 M $ al 31/08/2026
Josef Parvizi is the founder of Ceribell, Inc., founded in 2014, holding the title of Director since 2024.
Dr. Parvizi currently works at Stanford University School of Medicine since 2007, holding the title of Professor since 2017.
Dr. Parvizi has earned doctorates from the University of Iowa and the University of Oslo.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CERIBELL, INC. 5,23 % | 02/06/2026 | 2.007.489 ( 5,23 % ) | 48 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CERIBELL, INC. | Fundador | 29/08/2014 |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/07/2007 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ceribell, Inc.
Ceribell, Inc. Medical SpecialtiesHealth Technology Develops electroencephalography medical device and related AI based platform | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.